clinical 789 words KG: NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory 2026-03-28
kind:clinical-trialsection:clinical-trialstopic:alzheimersstate:published
Contents

NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory

Knowledge Graph

Related Hypotheses (10)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.78
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.65
TREM2-Dependent Microglial Senescence Transition
Score: 1.00
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.84

Related Analyses (10)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived

Related Experiments (6)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40

Knowledge Graph (1 edges)

NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory references TREM2